Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2019

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions

Diabetes Mellitus

Interventions

DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Placebo

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (1)

Investigational Site Number 1560001, Beijing